Bruce & Co is an investment fund managing more than $299 billion ran by R. Bruce. There are currently 38 companies in Bruce’s portfolio. The largest investments include Uhaul B and Merck, together worth $60.4 billion.
As of 2nd August 2024, Bruce & Co’s top holding is 542,950 shares of Uhaul B currently worth over $32.6 billion and making up 10.9% of the portfolio value.
In addition, the fund holds 224,500 shares of Merck worth $27.8 billion.
The third-largest holding is Abbvie Inc worth $27.7 billion and the next is NextEra Inc worth $23.6 billion, with 333,300 shares owned.
Currently, Bruce & Co's portfolio is worth at least $299 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Bruce & Co office and employees reside in Chicago, Illinois. According to the last 13-F report filed with the SEC, R. Bruce serves as the Vice President at Bruce & Co.
In the most recent 13F filing, Bruce & Co revealed that it had opened a new position in
Bunge and bought 50,000 shares worth $5.34 billion.
The investment fund also strengthened its position in Uhaul B by buying
6,600 additional shares.
This makes their stake in Uhaul B total 542,950 shares worth $32.6 billion.
On the other hand, R. Bruce disclosed a decreased stake in Xel Energy by 0.3%.
This leaves the value of the investment at $10.5 billion and 196,000 shares.
The two most similar investment funds to Bruce & Co are O'keefe Stevens Advisory and Atlantic Edge Private Wealth Management. They manage $299 billion and $299 billion respectively.
Bruce & Co’s portfolio is diversified across 8 sectors.
Currently, their heaviest sector is Utilities — making up 23.5% of
the total portfolio value.
The fund focuses on investments in the United States as
44.7% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
21% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $171 billion.
These positions were updated on August 9th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
Security | Shares Owned | Value | Allocation |
---|---|---|---|
Uhaul B |
1.23%
542,950
|
$32,587,859,000 | 10.89% |
Merck |
1.72%
224,500
|
$27,793,100,000 | 9.29% |
Abbvie Inc |
17.03%
161,500
|
$27,700,480,000 | 9.26% |
NextEra Energy Inc |
13.52%
333,300
|
$23,600,973,000 | 7.89% |
Allstate |
2.59%
130,500
|
$20,835,630,000 | 6.96% |
Duke Energy Corp. |
0.94%
205,816
|
$20,628,938,000 | 6.89% |
CMS Energy Corporation |
1.27%
320,000
|
$19,049,600,000 | 6.37% |
At & T |
2.39%
984,000
|
$18,804,240,000 | 6.29% |
Abbott |
1.53%
152,300
|
$15,825,493,000 | 5.29% |
Insteel |
No change
343,423
|
$10,632,376,000 | 3.55% |
Xel Energy |
33.11%
196,000
|
$10,468,360,000 | 3.50% |
Apple Inc |
13.11%
39,700
|
$8,361,614,000 | 2.79% |
Pfizer Inc. |
2.94%
276,400
|
$7,733,672,000 | 2.58% |
Avista Corp. |
No change
201,500
|
$6,973,915,000 | 2.33% |
Darling Ingredients Inc |
7.14%
150,000
|
$5,512,500,000 | 1.84% |
Bunge |
Opened
50,000
|
$5,338,500,000 | 1.78% |
Uhaul |
6.07%
75,105
|
$4,636,232,000 | 1.55% |
Newmont Corp |
52.44%
100,000
|
$4,187,000,000 | 1.40% |
Bausch Health |
14.60%
550,000
|
$3,833,500,000 | 1.28% |
RLI Corp. |
1,020.00%
22,400
|
$3,151,456,000 | 1.05% |
Archer Daniels |
Opened
50,000
|
$3,022,500,000 | 1.01% |
Edap |
No change
553,652
|
$3,011,867,000 | 1.01% |
Vicor Corp. |
133.33%
70,000
|
$2,321,200,000 | 0.78% |
Supernus |
No change
82,105
|
$2,196,309,000 | 0.73% |
Xm Sirius |
No change
557,843
|
$1,578,696,000 | 0.53% |
Ashland Inc |
No change
15,000
|
$1,417,350,000 | 0.47% |
Lava Theraputics |
No change
771,874
|
$1,389,373,000 | 0.46% |
Mannkind Corp |
No change
195,073
|
$1,018,281,000 | 0.34% |
Kodiak Sciences Inc |
10.57%
423,000
|
$994,050,000 | 0.33% |
Fate Theraputics |
109.79%
300,000
|
$984,000,000 | 0.33% |
Igm Bioscience |
53.85%
100,000
|
$687,000,000 | 0.23% |
Organon |
0.58%
31,370
|
$649,359,000 | 0.22% |
Viatris Inc. |
1.00%
58,833
|
$625,395,000 | 0.21% |
Caribou Biosciences |
50.00%
300,000
|
$492,000,000 | 0.16% |
Wec Energy |
Opened
4,509
|
$353,776,000 | 0.12% |
908 Devices Inc. |
No change
68,286
|
$351,673,000 | 0.12% |
Personalis Inc |
No change
300,000
|
$351,000,000 | 0.12% |
Warner Bros. Discovery |
11.36%
11,851
|
$88,171,000 | 0.03% |
No transactions found | |||
Showing first 500 out of 38 holdings |